PM&R Meeting Abstracts

Official abstracts site for the AAPM&R Annual Assembly and the PM&R Journal.

MENU 
  • Home
  • Meetings Archive
    • AAPM&R Annual Assembly 2022
    • AAPM&R Annual Assembly 2021
    • AAPM&R Annual Assembly 2020
    • AAPM&R Annual Assembly 2019
  • Resources
  • Advanced Search

Cancer Recurrence, Cachexia, Lower Creatinine and Reduced Performance on 6 Minute Walk Test Are Novel Factors Associated with Unplanned Transfers to Acute Care in Cancer Rehabilitation

Akash Bhakta, DO MHA (McGaw Medical Center of Northwestern University (Shirley Ryan AbilityLab) PM&R Program, Chicago, IL, United States); Ishan Roy; Kevin I. Huang, DO; Jacqueline M. Spangenberg; Prakash Jayabalan

Meeting: AAPM&R Annual Assembly 2019

Session Information

Date: Saturday, November 16, 2019

Session Title: General Rehabilitation Case & Research Report

Session Time: 11:15am-12:45pm

Location: Research Hub - Kiosk 1

Disclosures: Akash Bhakta, DO MHA: Nothing to disclose

Objective: Patients undergoing cancer rehabilitation have high rates of unplanned transfers. A majority of prior studies have been done in tertiary cancer center settings with the CMS diagnostic criteria waiver. The objective of our study was to determine risk factors that impact unplanned transfers (UPT) to acute care in patients with cancer undergoing inpatient rehabilitation.

Design: Retrospective Cohort Study

Setting: Freestanding Academic Acute Inpatient Rehabilitation Hospital

Participants: 330 admissions to oncology services in an acute inpatient rehabilitation (AIR) hospital.

Interventions: Data from initial evaluation upon inpatient rehabilitation admission, prior acute care admission, and ambulatory visits

Main Outcome Measures: Rate of and reasons for unplanned transfers to acute care.

Results: Overall rate of unplanned transfers was 36%. Factors associated with increased odds of UPT include: infection as reason for acute care admission (OR 2.2, P =.02), gastrointestinal malignancy as primary cancer (OR 3.5, P =.004), recurrent cancer (OR 3.7, P<.0001), development of cachexia in acute care (OR 2.1, P =.01), acute care length of stay >/= 10 days (OR 2.5, P =.0002), parenteral nutrition (OR 4.2, P =.01), graft vs host disease (OR 10.4, P =.04), pressure ulcers (OR 2.4, P =.001), admission creatinine.

Conclusions: We identified several novel factors associated with unplanned transfer from rehabilitation in cancer patients. These factors include cancer recurrence, cachexia, low creatinine, and poor 6 minute walk test. These findings will provide a framework for creating predictive tools for unplanned transfers in cancer rehabilitation patients.

Level of Evidence: Level III

To cite this abstract in AMA style:

Bhakta A, Roy I, Huang KI, Spangenberg JM, Jayabalan P. Cancer Recurrence, Cachexia, Lower Creatinine and Reduced Performance on 6 Minute Walk Test Are Novel Factors Associated with Unplanned Transfers to Acute Care in Cancer Rehabilitation [abstract]. PM R. 2019; 11(S2)(suppl 2). https://pmrjabstracts.org/abstract/cancer-recurrence-cachexia-lower-creatinine-and-reduced-performance-on-6-minute-walk-test-are-novel-factors-associated-with-unplanned-transfers-to-acute-care-in-cancer-rehabilitation/. Accessed May 12, 2025.
  • Tweet
  • Email
  • Print

« Back to AAPM&R Annual Assembly 2019

PM&R Meeting Abstracts - https://pmrjabstracts.org/abstract/cancer-recurrence-cachexia-lower-creatinine-and-reduced-performance-on-6-minute-walk-test-are-novel-factors-associated-with-unplanned-transfers-to-acute-care-in-cancer-rehabilitation/

Leading the Way. Baltimore, MD & Virtual. October 20-23, 2022. #aapmr22

PM&R Journal

View issues of PM&R on the Wiley Online Library »

American Academy of Physical Medicine and Rehabilitation

Visit the official site for the American Academy of Physical Medicine and Rehabilitation »

AAPM&R Annual Assembly

Visit the official site for the AAPM&R Annual Assembly »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 John Wiley & Sons, Inc. All Rights Reserved.
Wiley